HomeANNX • STO
add
Annexin Pharmaceuticals AB (publ)
Previous close
kr 31.00
Day range
kr 28.90 - kr 31.10
Year range
kr 22.10 - kr 91.00
Market cap
212.48M SEK
Avg Volume
19.55K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.99M | -35.31% |
Net income | -7.97M | 36.00% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.94M | 35.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 45.23M | 474.70% |
Total assets | 48.01M | 306.51% |
Total liabilities | 5.13M | -6.11% |
Total equity | 42.88M | — |
Shares outstanding | 6.62M | — |
Price to book | 4.78 | — |
Return on assets | -59.57% | — |
Return on capital | -70.57% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -7.97M | 36.00% |
Cash from operations | -8.25M | 39.05% |
Cash from investing | — | — |
Cash from financing | 36.98M | 369,930.00% |
Net change in cash | 28.89M | 313.30% |
Free cash flow | -5.27M | 40.11% |
About
Founded
2014
Website
Employees
4
